Clinical Trial Update: Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis Drugs

View source ↗

Summary

This clinical trial update analyzes risk factors for liver injury in a multiethnic population treated with antituberculosis drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Ethambutol (ethambutol)
• ISONIAZID (ISONIAZID)
• Pyrazinamide (pyrazinamide)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Stefania Cheli | Conditions: Tuberculosis Infection | Status: ACTIVE_NOT_RECRUITING